Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
Holders of 5% or more of CLDI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Calidi Biotherapeutics, Inc., largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Calidi Biotherapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 20259:15 AM ET | Lincoln Alternative Strategies LLC | 13G | 14.46%730.0K shares | New | Aug 20, 2025 | SEC |
| Aug 14, 20259:05 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%117.4K shares | −5.00 ppfrom 9.99%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:14 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%3.36M shares | New | Mar 31, 2025 | SEC |
| May 1, 202412:57 PM ET | Kessler Judd S | 13D | 5.00%3.73M shares | New | May 1, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Calidi Biotherapeutics, Inc. shares.
No Form 144 notices for Calidi Biotherapeutics, Inc. are on file.